half life of semaglutide injection Dosage Chart for Weight Loss & Dosing Guide half life of semaglutide injection

Candidates for supervised discontinuation: Maintained goal weight on a stable dose for 12 or more months Lost weight primarily through combined medication and lifestyle change (not medication alone) Consume 1.2 to 1.6 g protein per kg body weight daily Perform resistance training 3 or more times per week Sleep 7 or more hours nightly with good sleep architecture Have a BMI at goal of 25 or higher (patients who drop into the low-normal range have less metabolic buffer) No history of binge eating disorder or significant emotional eating patterns Even with this profile, the SURMOUNT-4 data suggests that roughly half of patients will regain meaningful weight within 12 months of stopping (Aronne et al., JAMA 2024)

Gastrointestinal side effects represent the most commonly reported adverse events with tirzepatide therapy, occurring in a substantial proportion of patients during clinical trials

Testers felt they could go for longer periods without eating, and no other side effects occurred

to review how tirzepatide works in your body and plan your weekly dosing safely

Managing Weight During Pregnancy After Tirzepatide Once you stop tirzepatide and begin pregnancy, appetite suppression will fade over 46 weeks as the medication fully clears

This relationship is linear and predictable